Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.
| Website: | www.guardanthealth.com |
| Email: | investors@guardanthealth.com |
| Main Phone: | +1 855 698-8887 |
| Address: | 505 Penobscot Drive |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94063 |
| Exchange: | NGS |
| CEO: | Helmy Eltoukhy |
| Employees: | 454 |
| NAICS: | Medical Laboratories(621511) |
Cloudflare's IPO last week continues to trade well.
80 deals created $44.8 billion of market value for newly public US biotechs (Image: Genomics Law Report).
Co-founder Jonathan Lim, MD, was CEO of Ignyta, which was acquired by Roche in February 2018 for $1.7 billion.
Guardant Health Inc is a precision oncology company. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. The company only reportable segment: delivering precision oncology testing and development services. Geographically, the company generates a majority of its revenue from the United States. its solutions include treatment selection, recurrence, and early detection.
| Website: | www.guardanthealth.com |
| Email: | investors@guardanthealth.com |
| Main Phone: | +1 855 698-8887 |
| Address: | 505 Penobscot Drive |
| State: | CA |
| City / Town: | Redwood City |
| Country: | USA |
| Postal Code: | 94063 |
| Exchange: | NGS |
| CEO: | Helmy Eltoukhy |
| Employees: | 454 |
| NAICS: | Medical Laboratories(621511) |
Cloudflare's IPO last week continues to trade well.
80 deals created $44.8 billion of market value for newly public US biotechs (Image: Genomics Law Report).
Co-founder Jonathan Lim, MD, was CEO of Ignyta, which was acquired by Roche in February 2018 for $1.7 billion.
| Last Price 80.01 | Change $ 2.66 | Change % 3.44 | Tick N/A |
| Bid 78.55 | Bid Size 400.00 | Ask 81.00 | Ask Size 100.00 |
| Open 77.69 | High 80.37 | Low 77.25 | Prev Close 77.35 |
| Last Trade | Volume 949,629 | 52 Wk Hi 112.22 | 52 Wk Low 31.06 |
| Market Cap 7.5 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 93,905,925.00 | EPS (TTM) -2.65 | PE Ratio N/A | Exchange NGS |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 55 | 55 | 55 | 55 |
| Low Target Price Estimate | 37 | 37 | 37 | 37 |
| Mean Target Price Estimate | 43.5 | 43.5 | 43.5 | 43.5 |
| Standard Deviation | 7.94 | 7.94 | 7.94 | 7.94 |
| Date of Most Recent Estimate | 11/21/18 | 11/21/18 | 11/21/18 | 11/21/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 110 | 2018-11-19 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2018-11-19 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-10-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-10-11 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-10-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-10-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-10-11 |
| 3/A | Amendment to a previously filed Form 3 | 1 | 2018-10-11 |
| 3/A | Amendment to a previously filed Form 3 | 1 | 2018-10-11 |
| 3/A | Amendment to a previously filed Form 3 | 1 | 2018-10-11 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 0 | 0 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.4 | 1.4 | 0 | 0 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait